Status | Study |
Recruiting |
Study Name: A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants Condition: Mucopolysaccharidosis I Hurler's Syndrome Hurler- Date: 2007-01-03 Interventions: Biological: Aldurazyme (laronidase) dose of 0.58mg/kg body weight intravenously (IV) every week |
Completed |
Study Name: Study of Aldurazyme® Replacement Therapy in Patients With Mucopolysaccharidosis I (MPS I) Disease Condition: Mucopolysaccharidosis I Hurler Syndrome Hurler- Date: 2005-11-22 Interventions: Biological: Aldurazyme (Recombinant Human Alpha-L-Iduronidase) 0.58 mg/kg every week |
Completed |
Study Name: Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients Condition: Mucopolysaccharidosis I Hurler's Syndrome Hurler- Date: 2005-09-02 Interventions: Biological: Aldurazyme Placebo |
Completed |
Study Name: A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Years Old Condition: Mucopolysaccharidosis I Hurler Syndrome Hurler- Date: 2005-09-02 Interventions: Biological: Aldurazyme (Recombinant Human Alpha-L-Iduronidase) |
Completed |
Study Name: A Dose-optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease Condition: Mucopolysaccharidosis I Hurler's Syndrome Hurler- Date: 2005-09-02 Interventions: Biological: Aldurazyme (Recombinant Human Alpha-L-Iduronidase) |
Completed |
Study Name: A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients Condition: Mucopolysaccharidosis I Hurler's Syndrome Hurler- Date: 2005-09-02 Interventions: Drug: laronidase dose of 0.58mg/kg body weight IV every week |
Recruiting |
Study Name: Mucopolysaccharidosis I (MPS I) Registry Condition: Mucopolysaccharidosis I (MPS I) Date: 2005-09-02 |